• Please log in or register to access this feature.

Perspective

You have full text access to this OnlineOpen article

In Silico Modeling and Simulation of Bone Biology: A Proposal

  1. Nadine A Defranoux1,†,
  2. Cynthia L Stokes1,†,
  3. Daniel L Young1,†,
  4. Arnold J Kahn PhD2,†,*

Article first published online: 4 APR 2005

DOI: 10.1359/JBMR.050401

Issue

Journal of Bone and Mineral Research

Journal of Bone and Mineral Research

Volume 20, Issue 7, pages 1079–1084, July 2005

Additional Information

How to Cite

Defranoux, N. A., Stokes, C. L., Young, D. L. and Kahn, A. J. (2005), In Silico Modeling and Simulation of Bone Biology: A Proposal. J Bone Miner Res, 20: 1079–1084. doi: 10.1359/JBMR.050401

Author Information

  1. 1

    In Silico R&D Department, Entelos, Inc., Foster City, California, USA

  2. 2

    Departments of Cell and Tissue Biology and Growth and Development, School of Dentistry, University of California, San Francisco, California, USA

  1. †

    Drs Defranoux, Stokes, and Young are employees of and own stock in Entelos, Inc. Dr Kahn has no conflict of interest.

*Growth and Development, Aging Research, Department of Cell and Tissue Biology, University of California San Francisco, 521 Parnassus Avenue, Box 0640, San Francisco, CA 94143-0640, USA., 415-476-9013 (voice), 415-476-1499 (fax)

  1. †

    Drs Defranoux, Stokes, and Young are employees of and own stock in Entelos, Inc. Dr Kahn has no conflict of interest.

Publication History

  1. Issue published online: 4 DEC 2009
  2. Article first published online: 4 APR 2005
  3. Manuscript Accepted: 4 APR 2005
  4. Manuscript Revised: 9 MAR 2005
  5. Manuscript Received: 28 OCT 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (321K)

REFERENCES

  • 1
    Helmick CG, Lawrence RC, Pollard RA, Lloyd E, Heyse SP 1995 Arthritis and other rheumatic conditions: Who is affected now, who will be affected later? Natl Arthr Data Workgroup Arthritis Care Res 8: 203–211.
  • 2
    National Osteoporosis Foundation 2004 Osteoporosis: Fast facts. Available online at http://www.nof.org/osteoporosis/diseasefacts.htm. Accessed August 8, 2004.
  • 3
    Frost HM 1973 Bone Modeling and Skeletal Modeling Errors. Orthopedic Lectures, vol. 1. C.C. Thomas, Springfield, IL, USA, p. 214.
  • 4
    Frost HM 1987 The mechanostat: A proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. Bone Miner 2: 73–85.
  • 5
    Zippel H 1992 Julius Wolff and the law of bone remodelling. In: RegelingG (ed.) Wolff's Law and Connective Tissue Regulation. Walter de Gruyter, New York, NY, USA, pp. 1–12.
  • 6
    Turner CH 1999 Toward a mathematical description of bone biology: The principle of cellular accommodation. Calcif Tissue Int 65: 466–471.
  • 7
    van der Linden JC, Birkenhager-Frenkel DH, Verhaar JA, Weinans H 2001 Trabecular bone's mechanical properties are affected by its non-uniform mineral distribution. J Biomech 34: 1573–1580.
  • 8
    Hernandez CJ, Beaupre GS, Carter DR 2003 A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos Int 14: 843–847.
  • 9
    Huiskes R, Ruimerman R, van Lenthe GH, Janssen JD 2000 Effects of mechanical forces on maintenance and adaptation of form in trabecular bone. Nature 405: 704–706.
  • 10
    Lemaire V, Tobin FL, Greller LD, Cho CR, Suva LJ 2004 Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. J Theor Biol 229: 293–309.
  • 11
    Paglia F, Dionisi S, De Geronimo S, Rosso R, Romagnoli E, Raejntroph N, Ragno A, Celi M, Pepe J, D'Erasmo E, Minisola S, Raejentroph N 2001 Biomarkers of bone turnover after a short period of steroid therapy in elderly men. Clin Chem 47: 1314–1316.
  • 12
    Saag KG 2004 Prevention of glucocorticoid-induced osteoporosis. South Med J 97: 555–558.
  • 13
    USA FDA 2004 Innovation/Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products. Available online at http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.pdf. Accessed October 19, 2004.
View Full Article (HTML) Get PDF (321K)